(Q34734995)

English

Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

8828024

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8828024%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

title

Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

8828024

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8828024%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

main subject

placebo

0 references

multicenter clinical trial

0 references

1 reference

1 reference

B Kalis

1

1 reference

stated in

Europe PubMed Central

PubMed ID

8828024

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8828024%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

publication date

1 January 1996

1 reference

stated in

Europe PubMed Central

PubMed ID

8828024

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8828024%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

Europe PubMed Central

PubMed ID

8828024

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8828024%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

volume

52 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed ID

8828024

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8828024%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

page(s)

30-34

1 reference

stated in

Europe PubMed Central

PubMed ID

8828024

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8828024%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

exact match

https://scigraph.springernature.com/pub.10.2165/00003495-199600521-00008

0 references

cites work

Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8828024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8828024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8828024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

(Q34734995)

Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)